Predictors of discontinuation, efficacy, and safety of memantine treatment for Alzheimer’s disease: meta-analysis and meta-regression of 18 randomized clinical trials involving 5004 patients

Abstract Background The risk-benefit relationship of memantine treatment for Alzheimer’s disease (AD) remains unclear. In addition, variability between the results of clinical trials has been observed. The aim of this study was to investigate the risk-benefit relationship of memantine treatment in p...

詳細記述

書誌詳細

出版年:	BMC Geriatrics
主要な著者:	Lídia Blanco-Silvente, Dolors Capellà, Josep Garre-Olmo, Joan Vilalta-Franch, Xavier Castells
フォーマット:	論文
言語:	英語
出版事項:	BMC 2018-07-01
主題:	Alzheimer’s disease Memantine Discontinuation Efficacy Meta-analysis Meta-regression
オンライン･アクセス:	http://link.springer.com/article/10.1186/s12877-018-0857-5